Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Indications for Biological Treatment Combined with Allergen-Specific Immunotherapy: Who Is It Really Intended for?

The use of omalizumab, in combination with AIT, has proven to be an effective option in treating patients with allergic asthma and during food desensitization, particularly in the dose escalation phase when adverse reactions are more common.

M. Turkalj, I. Banić · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.